Skip to content

Latest

Drug chains, suppliers gear up for flu season

Chain drug retailers are readying now to deliver millions of flu shots starting as early as next month. The flu season is expected to start in the fall, and eight flu vaccines from six companies have been approved by the Food and Drug Administration, precluding a repeat of last year’s concerns over

Navarro kicks off renovation program with flagship store

Navarro Discount Pharmacies has upgraded and reopened its flagship store in Miami and plans similar upgrades for other drug store locations. The retailer recently held a grand reopening of its original store at 1243 S.W. 8 St. in Miami, which opened in 1961 as El Nacional Drug Store.

Kerr appoints Domann as VP

Former pharmaceutical company executive Richard Domann has joined Kerr Drug’s Kerr Health subsidiary. Domann, who has more than three decades of experience in the drug industry, is the company’s vice president of sales and business development.

Lessons of the SKU rationalization debate

Though the year is barely half over, the major story of 2010 is clearly the retailer rush to pare assortments, popularly known as SKU rationalization. This exercise in reducing the number of items on retailer shelves has taken on a life of its own.

Rx operators adjust to changing paradigm

The Obama administration has begun the slow, laborious process of implementing the Affordable Care Act, legislation that will bring momentous changes to the nation’s health care system by the time its major provisions take effect in 2014.

NCPA gives take on Rx in grandfathered health plans

The National Community Pharmacists Association has submitted comments to a trio of federal agencies to emphasize patient choice and greater use of generic drugs as they devise criteria for maintaining Grandfathered Health Plan (GHP) status under the Patient Protection and Affordable Care Act (PPACA)

NBTY sets shareholder vote on sale of company

NBTY Inc. next month plans to hold a special meeting of shareholders to vote on its agreement to be acquired by private equity firm Carlyle Group. The nutritional supplements manufacturer and marketer said Tuesday that it has scheduled a meeting of stockholders on Sept.